Net Loss per Share (Tables)

9 Months Ended

Sep. 30, 2026

Earnings Per Share [Abstract]

Shares Not Included in Computation of Diluted Net Loss Per Share

The following shares were not considered in the computation of diluted net loss per share because their effect was anti-dilutive (in thousands):

	Three Months Ended September 30,		Nine Months Ended September 30,
	2026	2025	2026	2025
Shares issuable under the Equity Incentive Plan and ESPP(1)	14,807	13,286	14,807	13,286
Warrants(2)	424	424	424	424
Total potentially dilutive securities	15,231	13,710	15,231	13,710

(1) Included anti-dilutive potential common shares issuable under the ESPP of 343,158 shares for each of the three and nine months ended September 30, 2026 and 688,219 shares for each of the three and nine months ended September 30, 2025 (actual shares).

(2) Pertains to the warrants issued in connection with the Innovatus Loan. For additional information, see Note 11, “Debt.”